Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study
Abstract Background Endometrial cancer is closely linked to obesity and type 2 diabetes mellitus (T2DM). Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally developed for diabetes, demonstrate potential anti-cancer properties. This study aims to investigate the association between SGLT2i...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2025-07-01
|
| Σειρά: | BMC Cancer |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12885-025-14453-w |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|